Skip to main content
logo
Galectin Therapeutics Inc. (GALT)
NASDAQ: GALT · Real-Time Price · USD
2.790
+0.290 (11.60%)
At close: May 26, 2026, 4:00 PM EDT
2.824
+0.034 (1.23%)
After-hours: May 26, 2026, 5:18 PM EDT

Galectin Therapeutics Market Cap

Galectin Therapeutics has a market cap or net worth of $183.74 million as of May 26, 2026. Its market cap has increased by 107.62% in one year.

Market Cap
183.74M
Enterprise Value
308.00M
1-Year Change
107.62%
Ranking
#3944
Category
Micro-Cap
Stock Price
$2.79

Market Cap Chart

Since September 10, 2003, Galectin Therapeutics's market cap has increased from $106.80M to $183.74M, an increase of 72.04%. That is a compound annual growth rate of 2.42%.

History

DateMarket Cap% Change
May 22, 2026164.60M-38.63%
Dec 31, 2025268.20M231.11%
Dec 31, 202481.00M-21.13%
Dec 29, 2023102.70M52.83%
Dec 30, 202267.20M-45.28%
Dec 31, 2021122.80M-3.99%
Dec 31, 2020127.90M-21.39%
Dec 31, 2019162.70M15.31%
Dec 31, 2018141.10M18.57%
Dec 29, 2017119.00M313.19%
Dec 30, 201628.80M-26.53%
Dec 31, 201539.20M-48.96%
Dec 31, 201476.80M-48.11%
Dec 31, 2013148.00M352.60%
Dec 31, 201232.70M-55.81%
Dec 30, 201174.00M32.14%
Dec 31, 201056.00M288.89%
Dec 31, 200914.40M234.88%
Dec 31, 20084.30M-84.81%
Dec 31, 200728.30M111.19%
Dec 29, 200613.40M-83.91%
Dec 30, 200583.30M21.96%
Dec 31, 200468.30M-23.94%
Dec 31, 200389.80M-15.92%
Sep 10, 2003106.80M-
View and export this data all the way back to 2003. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

CompanyMarket Cap
Polaryx Therapeutics170.44M
OnKure Therapeutics170.06M
Protalix BioTherapeutics169.20M
Tenaya Therapeutics167.63M
Korro Bio167.45M
ProQR Therapeutics164.37M
Oramed Pharmaceuticals163.30M
Heron Therapeutics162.55M
Market Cap Rankings